254 related articles for article (PubMed ID: 21280156)
1. Krüppel-like family of transcription factor 9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells.
Ying M; Sang Y; Li Y; Guerrero-Cazares H; Quinones-Hinojosa A; Vescovi AL; Eberhart CG; Xia S; Laterra J
Stem Cells; 2011 Jan; 29(1):20-31. PubMed ID: 21280156
[TBL] [Abstract][Full Text] [Related]
2. Regulation of glioblastoma multiforme stem-like cells by inhibitor of DNA binding proteins and oligodendroglial lineage-associated transcription factors.
Wu Y; Richard JP; Wang SD; Rath P; Laterra J; Xia S
Cancer Sci; 2012 Jun; 103(6):1028-37. PubMed ID: 22380883
[TBL] [Abstract][Full Text] [Related]
3. Notch1 stimulation induces a vascularization switch with pericyte-like cell differentiation of glioblastoma stem cells.
Guichet PO; Guelfi S; Teigell M; Hoppe L; Bakalara N; Bauchet L; Duffau H; Lamszus K; Rothhut B; Hugnot JP
Stem Cells; 2015 Jan; 33(1):21-34. PubMed ID: 24898819
[TBL] [Abstract][Full Text] [Related]
4. DNER, an epigenetically modulated gene, regulates glioblastoma-derived neurosphere cell differentiation and tumor propagation.
Sun P; Xia S; Lal B; Eberhart CG; Quinones-Hinojosa A; Maciaczyk J; Matsui W; Dimeco F; Piccirillo SM; Vescovi AL; Laterra J
Stem Cells; 2009 Jul; 27(7):1473-86. PubMed ID: 19544453
[TBL] [Abstract][Full Text] [Related]
5. Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicity.
Sun P; Xia S; Lal B; Shi X; Yang KS; Watkins PA; Laterra J
BMC Cancer; 2014 Jun; 14():401. PubMed ID: 24893952
[TBL] [Abstract][Full Text] [Related]
6. Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures.
Kristoffersen K; Villingshøj M; Poulsen HS; Stockhausen MT
Cancer Biol Ther; 2013 Jul; 14(7):625-37. PubMed ID: 23792644
[TBL] [Abstract][Full Text] [Related]
7. Krüppel-like factor 9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells.
Tung B; Ma D; Wang S; Oyinlade O; Laterra J; Ying M; Lv SQ; Wei S; Xia S
BMC Cancer; 2018 Oct; 18(1):1025. PubMed ID: 30348136
[TBL] [Abstract][Full Text] [Related]
8. Kruppel-like factor-9 (KLF9) inhibits glioblastoma stemness through global transcription repression and integrin α6 inhibition.
Ying M; Tilghman J; Wei Y; Guerrero-Cazares H; Quinones-Hinojosa A; Ji H; Laterra J
J Biol Chem; 2014 Nov; 289(47):32742-56. PubMed ID: 25288800
[TBL] [Abstract][Full Text] [Related]
9. Loss of Krüppel-like factor 9 facilitates stemness in ovarian cancer ascites-derived multicellular spheroids via Notch1/slug signaling.
Wang K; Liu S; Dou Z; Zhang S; Yang X
Cancer Sci; 2021 Oct; 112(10):4220-4233. PubMed ID: 34363722
[TBL] [Abstract][Full Text] [Related]
10. A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling.
Yang F; Nam S; Brown CE; Zhao R; Starr R; Ma Y; Xie J; Horne DA; Malkas LH; Jove R; Hickey RJ
PLoS One; 2014; 9(4):e94443. PubMed ID: 24732116
[TBL] [Abstract][Full Text] [Related]
11. MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Krüppel-like factor 4.
Ma J; Yao Y; Wang P; Liu Y; Zhao L; Li Z; Li Z; Xue Y
Cancer Lett; 2014 Dec; 355(1):85-95. PubMed ID: 25218589
[TBL] [Abstract][Full Text] [Related]
12. Stanniocalcin-1 augments stem-like traits of glioblastoma cells through binding and activating NOTCH1.
Li Y; He ZC; Zhang XN; Liu Q; Chen C; Zhu Z; Chen Q; Shi Y; Yao XH; Cui YH; Zhang X; Wang Y; Kung HF; Ping YF; Bian XW
Cancer Lett; 2018 Mar; 416():66-74. PubMed ID: 29196129
[TBL] [Abstract][Full Text] [Related]
13. Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β.
Hardee ME; Marciscano AE; Medina-Ramirez CM; Zagzag D; Narayana A; Lonning SM; Barcellos-Hoff MH
Cancer Res; 2012 Aug; 72(16):4119-29. PubMed ID: 22693253
[TBL] [Abstract][Full Text] [Related]
14. Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo.
deCarvalho AC; Nelson K; Lemke N; Lehman NL; Arbab AS; Kalkanis S; Mikkelsen T
Stem Cells; 2010 Feb; 28(2):181-90. PubMed ID: 19937755
[TBL] [Abstract][Full Text] [Related]
15. Autophagy suppresses self-renewal ability and tumorigenicity of glioma-initiating cells and promotes Notch1 degradation.
Tao Z; Li T; Ma H; Yang Y; Zhang C; Hai L; Liu P; Yuan F; Li J; Yi L; Tong L; Wang Y; Xie Y; Ming H; Yu S; Yang X
Cell Death Dis; 2018 Oct; 9(11):1063. PubMed ID: 30337536
[TBL] [Abstract][Full Text] [Related]
16. The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets.
Cenciarelli C; Marei HE; Zonfrillo M; Casalbore P; Felsani A; Giannetti S; Trevisi G; Althani A; Mangiola A
Oncotarget; 2017 Mar; 8(11):17873-17886. PubMed ID: 28157712
[TBL] [Abstract][Full Text] [Related]
17. KLF9 Promotes Osteogenic Differentiation of Dental Stem Cells by Negatively Regulating Notch1 Mediated Signaling Pathway.
Zhao X; Mai Z; Lu Y; Cui L; Yu J
Front Biosci (Landmark Ed); 2023 May; 28(5):85. PubMed ID: 37258472
[TBL] [Abstract][Full Text] [Related]
18. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.
Fan X; Khaki L; Zhu TS; Soules ME; Talsma CE; Gul N; Koh C; Zhang J; Li YM; Maciaczyk J; Nikkhah G; Dimeco F; Piccirillo S; Vescovi AL; Eberhart CG
Stem Cells; 2010 Jan; 28(1):5-16. PubMed ID: 19904829
[TBL] [Abstract][Full Text] [Related]
19. Aberrant Notch signaling in glioblastoma stem cells contributes to tumor recurrence and invasion.
Yu JB; Jiang H; Zhan RY
Mol Med Rep; 2016 Aug; 14(2):1263-8. PubMed ID: 27315154
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.
Kristoffersen K; Nedergaard MK; Villingshøj M; Borup R; Broholm H; Kjær A; Poulsen HS; Stockhausen MT
Cancer Biol Ther; 2014 Jul; 15(7):862-77. PubMed ID: 24755988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
